Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT
Condition(s):Covid19; SARS-CoV2 Infection; COVID-19 PneumoniaLast Updated:October 25, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Covid19; SARS-CoV2 Infection; COVID-19 PneumoniaLast Updated:October 25, 2021Unknown status
Condition(s):Liver Fibroses; CirrhosisLast Updated:July 28, 2023Recruiting
Condition(s):Carotid Artery StenosisLast Updated:April 9, 2020Unknown status
Condition(s):Mild Cognitive ImpairmentLast Updated:January 12, 2024Recruiting
Condition(s):Tuberculosis, Pulmonary; TuberculosisLast Updated:December 8, 2023Completed
Condition(s):Cholesterol Variability; Trained ImmunityLast Updated:July 7, 2023Recruiting
Condition(s):Hearing Loss; Head and Neck CancerLast Updated:March 27, 2024Not yet recruiting
Condition(s):Osteoporosis; HypercholesterolemiaLast Updated:May 20, 2021Completed
Condition(s):Myocardial EdemaLast Updated:August 23, 2018Completed
Condition(s):Metastatic Prostate Cancer; Recurrent Prostate CancerLast Updated:October 21, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.